Is Roselabs Finance overvalued or undervalued?

Oct 20 2025 08:05 AM IST
share
Share Via
As of October 17, 2025, Roselabs Finance is considered very attractive and undervalued despite negative financial ratios, particularly when compared to peers like Bajaj Finance and Life Insurance, and has recently outperformed the Sensex.
As of 17 October 2025, Roselabs Finance has moved from a grade of risky to very attractive, indicating a significant improvement in its valuation outlook. The company is currently considered undervalued despite its negative financial ratios, including a PE ratio of -110.34, an EV to EBITDA of -36.81, and a ROCE of -31.00%.

In comparison to its peers, Roselabs Finance's valuation metrics stand out starkly; for instance, Bajaj Finance has a PE ratio of 38.21, while Life Insurance shows a more favorable EV to EBITDA of 8.94. The stark contrast in these ratios suggests that Roselabs Finance may be undervalued relative to its peers, especially given its recent stock performance, which has outpaced the Sensex over the past week and month.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News